Toshiaki Jibiki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Toshiaki Jibiki has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Kumi Yasukawa
Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan
3 shared publicationsMasaki Kanazawa
Department of Pediatrics Chiba Kaihin Municipal Hospital Chiba Japan
3 shared publications- Masaru Terai
Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo-shi, Chiba, Japan
3 shared publications Takafumi Honda
Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan
3 shared publicationsYoichi Kohno
Chiba University
3 shared publications- Hiromichi Hamada
Department of Pediatrics Tokyo Women's Medical University Yachiyo Medical Center Chiba Japan
2 shared publications
Latest Publications
- 11 December 2013
- Published by Wiley in Pediatrics International
- Vol. 55 (6) , 771-775
Acute scrotum in Kawasaki disease: Two case reports and a literature review
Acute scrotum is a rare complication of acute Kawasaki disease (KD), less well recognized than other disease manifestations. We describe the cases of two patients, aged 59 months and 19 months, with hydrocele testis in the acute phase of KD. Scrotal ultrasound and trans‐illumination were used in the diagnosis of hydrocele testis. One patient underwent eventual surgical intervention. We reviewed the literature for a better understanding of the pathogenesis of scrotal symptoms in acute KD and investigated the clinical importance of hydrocele testis. Careful further clinical observation may elucidate the true incidence of this extracardiac symptoms, thereby clarifying the diagnostic value of this possible complication in acute KD.
- 11 December 2013
- Published by Wiley in Pediatrics International
- Vol. 55 (6) , 771-775
Acute scrotum in Kawasaki disease: Two case reports and a literature review
Acute scrotum is a rare complication of acute Kawasaki disease (KD), less well recognized than other disease manifestations. We describe the cases of two patients, aged 59 months and 19 months, with hydrocele testis in the acute phase of KD. Scrotal ultrasound and trans‐illumination were used in the diagnosis of hydrocele testis. One patient underwent eventual surgical intervention. We reviewed the literature for a better understanding of the pathogenesis of scrotal symptoms in acute KD and investigated the clinical importance of hydrocele testis. Careful further clinical observation may elucidate the true incidence of this extracardiac symptoms, thereby clarifying the diagnostic value of this possible complication in acute KD.
- 26 July 2012
- Published by Wiley in Pediatrics International
- Vol. 54 (4) , 558-562
Myocarditis in a pediatric case of pandemic 2009H1N1 influenza
- 26 July 2012
- Published by Wiley in Pediatrics International
- Vol. 54 (4) , 558-562
Myocarditis in a pediatric case of pandemic 2009H1N1 influenza
- Open Access
- 22 February 2011
- Published by Wiley in Pediatrics International
- Vol. 53 (5) , 729-735
Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease
Background: The aim of the present study was to investigate the efficacy of i.v. immune globulin (IVIG) therapy combined with corticosteroids for additional treatment of acute Kawasaki disease (KD) unresponsive to initial IVIG treatment. Methods: In 50 prospective KD patients, six IVIG non-responders without clinical improvement within 24–48 h after completion of initial IVIG, received 2 g/kg IVIG concurrently with 2 mg/kg i.v. prednisolone sodium succinate (PSL) until normalization of C-reactive protein level. Treatment was then changed to oral PSL, which was tapered over time. Clinical and coronary artery lesion (CAL) outcomes were compared with those of 13 IVIG non-responders who received additional heterogeneous therapies in 125 retrospective KD patients. In addition, the scoring system of Kobayashi et al. for prediction of non-responsiveness to initial IVIG treatment was retrospectively verified in 175 KD subjects, consisting of 50 prospective and 125 retrospective patients in order to evaluate the efficacy of the re-treatment regimen. Results: Incidence of CAL in the study patients was lower than in the control patients, although differences were not significant both in the acute stage (within 1 month: 1/6, 16.7% vs 7/13, 53.8%; P= 0.177) and in the convalescent stage (after 1 month: 0/6, 0.0% vs 4/13, 30.8%; P= 0.255). According to the non-responder prediction system, the scores of six study and 13 control patients before initial IVIG treatment were similar (7.2 ± 1.9 vs 5.3 ± 3.1; P= 0.200). No serious adverse effects related to each treatment were noted in patients of either group. Conclusions: Additional IVIG combined with concurrent PSL appears to be safe and worth evaluation for the treatment of acute KD unresponsive to initial IVIG treatment.
- 22 February 2011
- Published by Wiley in Pediatrics International
- Vol. 53 (5) , 729-735
Open AccessIntravenous immune globulin plus corticosteroids in refractory Kawasaki disease
Background: The aim of the present study was to investigate the efficacy of i.v. immune globulin (IVIG) therapy combined with corticosteroids for additional treatment of acute Kawasaki disease (KD) unresponsive to initial IVIG treatment. Methods: In 50 prospective KD patients, six IVIG non-responders without clinical improvement within 24–48 h after completion of initial IVIG, received 2 g/kg IVIG concurrently with 2 mg/kg i.v. prednisolone sodium succinate (PSL) until normalization of C-reactive protein level. Treatment was then changed to oral PSL, which was tapered over time. Clinical and coronary artery lesion (CAL) outcomes were compared with those of 13 IVIG non-responders who received additional heterogeneous therapies in 125 retrospective KD patients. In addition, the scoring system of Kobayashi et al. for prediction of non-responsiveness to initial IVIG treatment was retrospectively verified in 175 KD subjects, consisting of 50 prospective and 125 retrospective patients in order to evaluate the efficacy of the re-treatment regimen. Results: Incidence of CAL in the study patients was lower than in the control patients, although differences were not significant both in the acute stage (within 1 month: 1/6, 16.7% vs 7/13, 53.8%; P= 0.177) and in the convalescent stage (after 1 month: 0/6, 0.0% vs 4/13, 30.8%; P= 0.255). According to the non-responder prediction system, the scores of six study and 13 control patients before initial IVIG treatment were similar (7.2 ± 1.9 vs 5.3 ± 3.1; P= 0.200). No serious adverse effects related to each treatment were noted in patients of either group. Conclusions: Additional IVIG combined with concurrent PSL appears to be safe and worth evaluation for the treatment of acute KD unresponsive to initial IVIG treatment.
- 8 September 2004
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 163 (12) , 749-750
High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease
- 8 September 2004
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 163 (12) , 749-750
High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 182
Effects of Intravenous Gammmaglobulin Therapy Combined with Dexamethasone for the Initial Treatment of Acute Kawasaki Disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 182
Effects of Intravenous Gammmaglobulin Therapy Combined with Dexamethasone for the Initial Treatment of Acute Kawasaki Disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 162
Mid-term Results of Heparin and Exercise Therapy for Patients with Myocardial Ischemia after Kawasaki Disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 162
Mid-term Results of Heparin and Exercise Therapy for Patients with Myocardial Ischemia after Kawasaki Disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 161
Possible Etiological Agents Inducing Macrophage Activation and Increased Vascular Permeability in Acute Kawasaki Disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 161
Possible Etiological Agents Inducing Macrophage Activation and Increased Vascular Permeability in Acute Kawasaki Disease